Establishment of a bi-layered tissue engineered conjunctiva using a 3D-printed melt electrowritten poly-(ε-caprolactone) scaffold.

"Declarations Competing interestsE.M.D. declares that she has a pending patent related to this research. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be seen as a potential conflict of interest Ethical approvalThe study was in strict accordance with the tenets of the Declaration of Helsinki. The research protocol was evaluated and approved by the Institutional Review Boards of the University of Miami, Miami, Florida, USA. Competing interests E.M.D. declares that she has a pending patent related to this research. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be seen as a potential conflict of interest"

"Funding VLP: Asclepix, Azura, Dompe, Kiora, Kala, Novartis, Oyster Point, Sight Sciences, Sun Pharmaceuticals, Trefoil, National Institutes of Health/National Eye Institute: R01EY030283 (Dr. Perez), R01EY024485 (Dr. Perez), Duke NIH Center Core Grant and Duke Research to Prevent Blindness Unrestricted Grant (Dr. Perez). The remaining authors declare no financial disclosures."